Falls Among the Older Patients Treated for Cancer in Normandy's Outclinics: Screening and Prevention

University Hospital, Caen328 enrolled

Overview

The French Plan National AntiChute (published on February 21, 2022) and international recommendations on falls prevention (Age Ageing,September 2022) recommend identifying the risk of falling in people aged 65 and over, at least once a year during a follow-up consultation. The presence of chronic illness such as cancer increases the risk for falling. Recommendations suggest targeted preventive interventions according to the risk level, and early reassessment at 3 months in case of high risk. This study consists of a cross-sectional survey conducted during a week dedicated to patient safety (September 16-20, 2024), to identify the prevalence of patients at high risk for falling, requiring enhanced care. The relation between high risk for falling and social and oncological characteristics will be studied. A 3-month telephone follow-up will identify any obstacles to implementing the recommendations in this high-risk group. This multicenter cross-sectional prospective study is exploratory.

Study Type

OBSERVATIONAL

Enrollment

328

Conditions

Aged Patients Treated for Cancer in Outclinics

Interventions

screening risk for falling and identifiy the risk level low-intermediate-high

3 key questions: Any posiitve answer to a) Has fallen in the past year? b) Feels unsteady when standing or walking? or c) Worries about falling? prompts to "fall severity" step. if "no" at the three questions= low level of fall-risk Fall severity: fall with injuires, laying on the ground with no capacity to get up, or a visit to emergency room, or loss of conscienciousness/suspected syncope. or Frailty (Clinical Frailty Scale)= if positive, high risk otherwise, 4 meter-walk test: if =\<0.8m/sec= intermediate risk if \>0.8m/sec=intermediate risk

Eligibility

Sex: ALLMin age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * aged 65 or over * undergoing treatment for cancer or hematological malignancy (oral or injectable systemic treatment, radiotherapy) * covered by health insurance * having read the information document and no objection * French-speaking * Autonomous ( with occasional assistance with instrumental daily activities), Exclusion Criteria: * refusal to participate * unable to communicate * dependent (requiring geriatric care)

Locations (10)

Caen UH

Caen, Normandy, France

Centre de radiothérapie de la Baie

Avranches, France

Centre de radiothérapie Maurice Tubiana/Polyclinique Parc

Caen, France

CLCC François Baclesse

Caen, France

Centre Hospitalier Public du Cotentin

Cherbourg, France

Centre Hospitalier Evreux-VErnon

Évreux, France

Hôpital Privé de l Estuaire

Le Havre, France

Centre Hospitalier Robert Bisson

Lisieux, France

Becquerel Cancer CEnter

Rouen, France

CHU de Rouen Charles Nicolle

Rouen, France

Outcomes

Primary Outcomes

prevalence of each of the three levels of fall-risk

describe the distribution of patients in mild, intermediate and high risk for falling

Time frame: Day 1

Secondary Outcomes

look for association between high-risk categorization and rural place of residence, gender, age bracket (65-74 and 75 and over), investigating center, type of cancer (location).

Time frame: Day 1

Describe the rate of high-risk patients who will have benefited from (full or partial) implementation of recommended interventions according to 3-month follow-up.

Time frame: 3 mnths

among high-risk patients followed up at 3 months, look for an association between the absence ofimplementation of recommendations and social, medical characteristics and motive

Time frame: 3 mnths

describe the Average number of STOPPFALL medications per patient. Rate of patients with at least one oncologydrug listed as a fall risk (CIPN), in the 3 fall risk categories

Time frame: Day 1